Clinical trials for Spinal muscular atrophy

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Spinal muscular atrophy. For all clinical trials, go to clinical trials search

This list shows clinical trials for Spinal muscular atrophy

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Spinal muscular atrophy
Title Recruitment status Location
An Open-Label Study (SHINE) for Patients With Spinal Muscular Atrophy (SMA) Who Participated in Studies With IONIS-SMNRx Recruiting United Kingdom
A Study of Multiple Doses of ISIS SMNRx (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy Recruiting United Kingdom
A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients With Spinal Muscular Atrophy Recruiting United Kingdom
An extension study for patients with Spinal Muscular Atrophy who participated to the previous ISIS 396443 studies Not Recruiting United Kingdom
Phase II, multicenter, randomized, adaptive, double-blind, placebo controlled study to assess safety and efficacy of olesoxime (TRO19622) in 3-25 year old Spinal Muscular Atrophy (SMA) patients. Not Recruiting United Kingdom
Phase II, multicenter, randomized, adaptive, double-blind, placebo controlled study to assess safety and efficacy of olesoxime (TRO19622) in 3-25 year old Spinal Muscular Atrophy (SMA) patients. Not Recruiting United Kingdom
Phase II, multicenter, randomized, adaptive, double-blind, placebo controlled study to assess safety and efficacy of olesoxime (TRO19622) in 3-25 year old Spinal Muscular Atrophy (SMA) patients. Not Recruiting United Kingdom
Acute Clinical Evaluation of Multi-purpose Solutions (MPS) in Soft Contact Lens Wearers Not recruiting United Kingdom
Outcome measures in SMA type II and III Not Recruiting United Kingdom
Phase II, multicenter, randomized, adaptive, double-blind,placebo controlled Study to assess Safety and Efficacy of olesoxime (TRO19622) in 3-25 year old Spinal Muscular Atrophy (SMA) patients Not Recruiting United Kingdom

Page last reviewed: 18/07/2011

Next review due: 18/07/2013